These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6991411)

  • 1. Bacteriostatic effect of serum: role of antibody to lipopolysaccharide.
    Fitzgerald SP; Rogers HJ
    Infect Immun; 1980 Feb; 27(2):302-8. PubMed ID: 6991411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric iron and the antibacterial effects of horse 7S antibodies to Escherichia coli O111.
    Rogers HJ
    Immunology; 1976 Mar; 30(3):425-33. PubMed ID: 815177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriostatic effect of human milk on Escherichia coli: the role of IgA.
    Rogers HJ; Synge C
    Immunology; 1978 Jan; 34(1):19-28. PubMed ID: 146678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibody and enterobactin in controlling growth of Escherichia coli in human milk and acquisition of lactoferrin- and transferrin-bound iron by Escherichia coli.
    Brock JH; Pickering MG; McDowall MC; Deacon AG
    Infect Immun; 1983 May; 40(2):453-9. PubMed ID: 6220972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-binding proteins in milk and resistance to Escherichia coli infection in infants.
    Bullen JJ; Rogers HJ; Leigh L
    Br Med J; 1972 Jan; 1(5792):69-75. PubMed ID: 4550126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial effect of the scandium and indium complexes of enterochelin on Escherichia coli.
    Rogers HJ; Woods VE; Synge C
    J Gen Microbiol; 1982 Oct; 128(10):2389-94. PubMed ID: 6218256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of E. coli.
    Reiter B; Brock JH; Steel ED
    Immunology; 1975 Jan; 28(1):83-95. PubMed ID: 1090522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
    Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
    J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-binding proteins and other factors in milk responsible for resistance to Escherichia coli.
    Bullen JJ
    Ciba Found Symp; 1976; (42):149-69. PubMed ID: 791596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.
    Gupta RK; Egan W; Bryla DA; Robbins JB; Szu SC
    Infect Immun; 1995 Aug; 63(8):2805-10. PubMed ID: 7542631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT; Bogard WC
    J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli.
    Chart H; Cheasty T; Willshaw GA
    J Med Microbiol; 2002 Dec; 51(12):1050-1054. PubMed ID: 12466402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum.
    Goldman RC; White D; Orskov F; Orskov I; Rick PD; Lewis MS; Bhattacharjee AK; Leive L
    J Bacteriol; 1982 Sep; 151(3):1210-21. PubMed ID: 6179923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
    Oishi K; Koles NL; Guelde G; Pollack M
    J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial effect of human serum IgA.
    Funakoshi S; Doi T; Nakajima T; Suyama T; Tokuda M
    Microbiol Immunol; 1982; 26(3):227-39. PubMed ID: 6287178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colitose-containing O-polysaccharide structure and O-antigen gene cluster of Escherichia albertii HK18069 related to those of Escherichia coli O55 and E. coli O128.
    Zheng H; Naumenko OI; Wang H; Xiong Y; Wang J; Shashkov AS; Li Q; Knirel YA
    Carbohydr Res; 2019 Jul; 480():73-79. PubMed ID: 31176878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.
    Russo TA; Sharma G; Brown CR; Campagnari AA
    Infect Immun; 1995 Apr; 63(4):1263-9. PubMed ID: 7890383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW; Voss E; Manning PA; Paton JC
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of Escherichia coli ferrienterochelin uptake by a normal human serum immunoglobulin.
    Moore DG; Earhart CF
    Infect Immun; 1981 Feb; 31(2):631-5. PubMed ID: 6452414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.